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Abstract
Background: Nuclear Factor-Kappa B (NF-kB) is a family of transcription factors that are important in embryonic
development, inflammation, epithelial-to-mesenchymal transition and cancer. The 65 kDa RelA subunit is the major
transcriptional activator of the NF-kB pathways. Whole-body deficiency of RelA leads to massive apoptosis of liver
hepatocytes and death in utero. To study the role of RelA in physiology and in disease states in a manner that
circumvents this embryonic lethal phenotype, we have generated a mouse with RelA conditional knockout (CKO)
alleles containing loxP sites that are deleted by activated Cre recombinase.
Results: We demonstrate that RelACKO/CKO mice are fertile, do not display any developmental defects and can be
crossed with Cre-expressing mice to delete RelA in a temporal, tissue-specific manner. Our mating of RelACKO/CKO
mice with Zp3-Cre transgenic led to embryonic lethality of RelA-deficient embryos. In contrast, mating of RelACKO/CKO
mice with Col1α2-CreER mice allowed for the generation of double transgenics which could be stimulated with
tamoxifen to induce fibroblast-specific RelA deletion in adulthood.
Conclusions: Based on our collective data, we conclude that this novel RelACKO/CKO mouse allows for efficient deletion
of RelA in a tissue-specific manner. This RelACKO/CKO mouse will be an invaluable tool for deciphering the mechanistic
roles of RelA in various cells and tissues during development and in disease.
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Background
NF-kB is an inducible transcription factor complex
involved in the regulation of genes necessary for cell
survival, differentiation, immunity and inflammation [1].
RelA, C-Rel and RelB are transcriptional activating sub-
units that contain a N-terminal Rel homology domain
(RHD) and a C-terminal transcription activation domain
(TAD) whereas NF-kB1 (p50/p105) and NF-kB2 (p52/
p100) are DNA-binding proteins that contain C-terminal
autoinhibitory ankyrin repeat domains [2]. In most
cells, NF-kB is high molecular weight heterodimeric
complexes containing a DNA-binding- and a transcription
activator subunit retained in the cytoplasm by Inhibitor of
kappa B (IkB) proteins. Receptor activation by numerous
ligands induces phosphorylation of IkBα, targeting it
for degradation and allowing nuclear translocation of
RelA•NF-kB1 dimers, the most abundant and most
potent transcription factor pair required for activation
of inflammatory and anti-apoptotic gene expression
programs [3].
Beg and colleagues were the first to describe the
lethality of whole-body RelA deficiency in mice [4]. Mat-
ing of RelA heterozygous mice failed to generate any
RelA-deficient (RelA-/-) animals and an analysis of em-
bryos indicated that RelA-/- embryos undergo massive
liver degeneration with hepatocyte apoptosis and conse-
quently die in utero. These findings were independently
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corroborated using a different gene-targeting vector [5].
This study demonstrated that when RelA-/- embryonic
livers are transplanted into SCID mice, T and B cells
populate spleen and lymph nodes to similar extent as
wild-type (WT) cells, suggesting that the lethal effect of
RelA-/- in utero is due to impairment of hepatocyte
development and not due to deranged hematopoiesis. In
a subsequent finding, the lethal phenotype of RelA-/-
was rescued by absence of TNFα [6]. RelA activation
downstream of the TNF-receptor is necessary for the
production of anti-apoptotic molecules, including
TRAF-1, TRAF-2, c-IAP1 AND c-IAP2 that protect cells
from local, endogenously produced TNFα-induced apop-
tosis [7, 8].
To overcome embryonic lethality produced by whole-
body RelA deletion and to investigate the role of RelA in
disease-specific states, investigators have generated
transgenic mice inserting loxP sites in the RelA gene
(RelA-floxed). DNA recombination mediated by Cre re-
combinase in RelA-floxed animals leads to truncation or
deletion of the RelA protein. Algul and colleagues cre-
ated a RelA-floxed mouse containing loxP sites in RelA
introns 6 and 10 [9]. Induction of Cre led to deletion of
exons 7–10, encoding the RHD, producing a truncated
RelA that failed to translocate to the nucleus. This strat-
egy results in expression of a truncated RelA C-terminal
TAD that potentially confounds the study. Recently,
another group created RelA-floxed mice with loxP sites
flanking the promoter region and exon 1 that resulted in
the deletion of RelA in B-cells when RelA-floxed animals
were crossed with CD19-Cre trasngenics [10]. The strat-
egy to excise only exon 1 of the RelA gene has the po-
tential to allow the expression of alternatively spliced
variants. In the case of RelA, there is putative internal
ribosome entry site (IRES) in exons 4–5 which allows
for 5′cap-indepedant translation [11]. Additionally, there
is evidence of alternatively spliced variants of RelA in
different cell types. For example, p65Δ variant lacks aa
222–231 and is abundantly expressed in pre-B and
erythroid colony forming cells [12]. During screening of
human adult osteoblastic cDNA library a RelA variant,
p65Δ2, has been found that lacks amino acids (aa) 13–
25 and 506 [13]. The N-terminus aa 13–25 are part of
the RHD, corresponding to exon 2 and 3, and may be
needed for binding to DNA. Although there has not
been any exhaustive investigation into alternative RelA
splicing variants, the presence of IRES in exons 4–5 and
existence of RelA NH2-terminal splice variants suggests
that some RelA transcripts may be produced in special-
ized cells under pathophysiological conditions that lack
exon 1 but still can undergo translation. These splice
variants would not be targeted in the flox mouse created
by Heise and colleagues. Furthermore, cells that undergo
recombination in the transgenic by Hesie et al. begin
expressing eGFP. This strategy makes it easier to track
recombined cells but the eGFP signal could be con-
founding in leukocytes, such as monocytes/macro-
phages, that have significant intracellular granules and
are autofluorescent in the same emission range as GFP
[14]. We decided to create a RelA-floxed mouse for in-
vestigating NF-kB signaling in vivo because, at the time,
no such experimental tool was commercially available.
Our group has developed a RelA-floxed transgenic
mouse that allows for complete deletion of RelA and
which will be made available for use by the scientific
community.
The mouse RelA gene, comprised of 11 exons, is
located within a 10.65-kb region on Chromosome 19.
Our strategy was to introduce two loxP sites into intron
4 and intron 8 of the RelA gene via gene targeting [RelA
conditional knockout (RelACKO) allele, Fig. 1]. In the pres-
ence of Cre recombinase, a 2.7-kb sequence containing
exons 5–8 would be excised from RelACKO/CKO generating
the RelA-/-. The deletion of exons 5–8, which encode the
C-terminus of its RHD (aa 113–292), results in a down-
stream frame-shift that will further lead to degradation of
RelA transcripts via nonsense-mediated mRNA decay.
Results and Discussion
The gene-targeting vector containing an frt-flanked neo-
mycin positive-selection cassette, and a thymidine kinase
negative-selection cassette (see Methods and Fig. 1) was
electroporated into 129B6F1 hybrid mouse embryonic
stem (ES) cells, G4 [15]. One hundred-forty ES cell col-
onies survived 9-days of double-drug selection. Colonies
were selected and propagated and DNA isolated from
the cells was screened for homologous recombinants by
Southern blotting. We found that twelve clones under-
went homologous recombination at the RelA locus, and
of those, three clones incorporated a “stand-alone” loxP
sequence in intron 8 (Fig. 1a). After further expansion
and repeated Southern blot analysis (Fig. 1b), all three
clones were injected into C57BL/6J blastocysts. We
then bred the resulting male chimeras with FLPeR
mice on a C57BL/6J background [B6.129S4-Gt(RO-
SA)26Sortm1(FLP1)Dym/RainJ, the Jackson Laboratory,
Stock Number: 009086] to obtain offspring double-
heterozygous for RelACKO allele and FLP1 knock-in allele.
The FLPeR mice express FLP1 recombinase in a wide
range of cell types including germ cells [16], and were
used for FLP-mediated removal of the neomycin cassette
from the mutant RelA allele (Fig. 2). Germ-line transmis-
sion of RelA mutation was achieved with two clones, 1–60
and 1–95. We then backcrossed double-heterozygous
mice to C57BL/6J mice to segregate the FLP1 transgene
and to establish RelACKO lines. Mice homozygous for
RelACKO allele (RelACKO/CKO) were normal, fertile and
expressed RelA at normal levels.
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To generate whole-body RelA deficient mice contain-
ing the knockout alleles [KO, Fig. 3], we first crossed a
RelACKO/+ mouse (1–60 line) and a Zp3-cre transgenic
mouse on a C57BL/6 background [C57BL/6J-Tg(Zp3-
cre)93Knw/J, The Jackson Laboratory, Stock Number:
003651, [17]], and obtained a RelACKO/+; Tg(Zp3-
cre)93Knw/0 female mouse. In Zp3-cre transgenic mice,
Cre expression is controlled by regulatory sequences
from the mouse zona pellucida 3 (Zp3) gene, which is
normally expressed exclusively in the growing oocytes,
and Cre-mediated loxP recombination occurs in 100 %
of oocytes [18]. Therefore, backcrossing the RelACKO/+;
Tg(Zp3-cre)93Knw/0 female mouse to a wild-type
C57BL/6J male results in offspring: RelA+/-; Tg(Zp3-
cre)93Knw/0, RelA+/+; Tg(Zp3-cre)93Knw/0, RelA+/- and
RelA+/+. The offspring were genotyped by Southern blot
(Fig. 3), and a RelA+/- mouse was backcrossed to C57BL/
6J mice for the propagation of the KO line. RelA+/- male
and female mating produced only RelA+/- and RelA+/+
embryos. Analysis of embryos at embryonic day 12 (E12)
demonstrated that almost a quarter of them had intraab-
dominal hemorrhages with no clear macroscopic discern-
ment of a liver (Fig. 4a). Genotyping verified that these
embryos were RelA-/-. Immunohistochemical analysis in-
dicated very high immunoreactivity for cleaved-caspase 3
in the liver, signifying aberrant apoptosis (Fig. 4b). To fur-
ther verify caspase-3 activation and apoptosis, we probed
for cleaved poly ADP-ribose polymerase (PARP)-1, a pro-
tein that is a target of activated caspase-3 in its latent
form. RelA-/- embryonic liver had robust immunostaining
of cleaved PARP-1 which was absent in RelA+/+ livers. Iso-
lated mouse embryonic fibroblasts (MEFs) were used to
verify DNA recombination and RelA mRNA and protein
depletion in RelA+/- and RelA-/- cells (Fig. 4c–e). We failed
to observe any shift in the RelA band (65 kDa) using the
Santa-Cruz antibody sc-372 that targets the TAD, suggest-
ing that a truncated RelA is not produced in the genetic-
ally recombined cells. Furthermore, immunohistochemical
analysis was performed using three different antibodies
targeting the N- and C-terminus domains of the RelA
protein (Fig. 5). All three antibodies demonstrated robust
RelA immunostaining in the liver, brain and vertebrae
of RelA+/+ embryos. Two antibodies targeting the C-
terminus failed to show any staining in the RelA-/-
embryos whereas slight staining was observed in the
liver with sc-109 antibody that recognizes the RHD at
the N-terminus. The minor staining could be due to
antibody cross-reactivity with other RHD-containing
proteins such as RelB or C-Rel. To verify that the
antibodies specifically recognized RelA, whole cell ly-
sates from A549 cell line were immunoprecipitated
with the three RelA antibodies and subjected to selected
reaction monitoring- mass spectrometry analysis (SID-
SRM-MS). Relative to IgG immunoprecipitates, there was
100-fold increase in RelA when immunoprecipitation was
performed with sc-109 and ab7970 antibodies and ap-
proximately a 200-fold increase in RelA when sc-372 anti-
body was used (Additional file 1: Figure S1). We interpret
Fig. 1 Strategy for targeted mutation of the RelA gene. a The open boxes represent exons 1–4, and 9–11; the solid boxes represent exons 5–8.
The solid lines represent intronic sequences; the dashed line represents plasmid vector DNA. The triangles represent loxP sequences and the ovals
represent frt sequences. The gene-targeting vector possesses a total of 7.2-kb homologous sequence. The PGKneobpA cassette was inserted into
an EcoRV site located ~0.6-kb upstream of exon 5. The second (stand-alone) loxP was inserted into an AflII site located ~240-bp downstream of
exon 8. The vector has a 2.9-kb 5′-homology arm, and a 3′-homology arm divided into 2.7-kb and 1.7-kb segments. Homologous recombination
between WT RelA and the targeting vector may result in a RelA mutant allele that carries both PGKneobpA cassette and the stand-alone loxP
[Targeted (floxed-neo) allele], or one that carries only PGKneobpA cassette [Targeted (neo) allele]. The 5′-flanking probe hybridized to EcoRV-
digested genomic DNA detects 4.8-kb WT bands, and 6.7-kb targeted allele bands; the 3′-flanking probe hybridized to Asp718-digested genomic
DNA detects 4.9-kb WT bands, 4.1-kb targeted (floxed-neo) allele bands, and 4.9-kb targeted (neo) allele bands. b Southern blot analysis of DNA
isolated from ES cell clones. Three clones, 1–60, 1–95, and 2–32, were found correctly targeted in the initial screening, and further expanded;
DNA was isolated and subjected to Southern blot analysis. DNA isolated from a random integration clone was used as a non-recombinant control
(Random). A restriction enzyme and a probe used in the analysis were indicated below each panel
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this to mean that all three antibodies recognize RelA and
RelACKO/CKO cells that have undergone DNA recombin-
ation at the RelA alleles do not produce RelA. To deter-
mine whether Cre-mediated recombination can also occur
in vitro, we transduced Cre via a lentivirus vector in
RelACKO/CKO MEFs. In experiments infecting MEFs with
only a multiplicity of infection (MOI) of 2, we observed a
90 % reduction in RelA protein (Fig. 4f) with no shift in
the RelA band. These data confirm that RelA can be
depleted both in vitro using RelACKO/CKO cells and in vivo
using our RelA CKO/CKO mice.
Our ultimate goal is to study the tissue-specific role of
RelA in vivo. We have previously demonstrated that
aortic fibroblasts produce significant amount of IL-6 and
MCP-1 that are NF-kB-dependent proteins, in vitro and
the secretion of these cytokine/chemokine increases
more than 2-fold in presence of monocytes [19, 20]. We
have defined this interaction to be occurring in vivo in
the aortic wall and contributing to aortic inflammation
and to the development of aortic dissections [19]. To
test the hypothesis that fibroblast-RelA contributes to
aortic inflammation, we have developed fibroblast-
specific RelA-/- mice by crossing a tamoxifen inducible
Col1α2-promoter driven Cre mouse (Col1α2-CreER) with
RelACKO/CKO mice. Although the characterization of
aortic fibroblast-RelA depletion and the role of fibroblast-
RelA in aortic inflammation are currently being inves-
tigated by our lab, we have described here the experi-
ments validating RelA depletion that also occurs in
skin fibroblast cells. After three generations of crosses,
RelACKO/CKO Cre + and RelACKO/CKO Cre- littermates
(Fig. 6a), which appeared normal and fertile, were treated
with tamoxifen and their skin fibroblasts were isolated for
characterization. Cre + fibroblasts had decreased levels of
RelA in their cytoplasm (white arrows in Fig. 6b) and in
response to TNFα stimulation, failed to accumulate RelA
in the nucleus. We observed that only 50 % of the fibro-
blast had decreased RelA immunostaining suggesting that
Fig. 2 Confirmation of PGKneobpA cassette removal. The internal probes hybridized to Asp718-digested genomic DNA detect 18.7-kb WT
bands, 3.7-kb targeted (floxed-neo) allele bands, and 2.0-kb CKO allele bands. Tail DNA was isolated from pups generated by mosaic females
(RelAfloxed-neo/+↔ RelACKO/+; Gt(ROSA)26SorFLP1/+) and a wild-type C57BL/6J male, and digested by Asp718. The blot was hybridized with the internal
probe 1. When the same filter was stripped and rehybridized with the 3′ probe, all CKO/+ and neo/+ samples showed 4.1-kb mutant bands and
4.9-kb WT bands (data not shown)
Ijaz et al. BMC Developmental Biology  (2016) 16:32 Page 4 of 10
tamoxifen administration affected only half of the skin
fibroblasts. Furthermore, RelA transcripts (Fig. 6c) and
protein (Fig. 6d) were depleted by approximately 50 % in
Cre + fibroblasts. Collectively, these data demonstrated that
Col1α2-CreER is efficiently activated in half of the dermal
fibroblasts by tamoxifen administration and can promote
the recombination of RelA alleles in these cells leading to
RelA depletion. Our future work will utilize this transgenic
mouse to explore the role of fibroblast-RelA in the devel-
opment of vascular inflammation and fibrosis in vivo.
Conclusion
In summary, we report the generation of a transgenic
mouse containing RelA-flox alleles that recombine in
the presence of active Cre recombinase to generate
RelA-/- cells. This will be an important tool for studies
investigating RelA signaling in adult tissues since it
allows one to bypass a major limitation, death in utero,
that accompanies whole-body RelA-/-. Furthermore, this
will be a valuable mouse model for exploring the role of
RelA in development, an under-explored area due to a
lack of appropriate tools for investigation.
Methods
Construction of the RelA conditional knockout vector
A 7.2-kb AfeI-HindIII DNA fragment (RelA 5′ up-
stream–intron 8 region) was isolated from a bacterial
artificial chromosome (BAC) clone, RP24-329M16 (ob-
tained from the Children’s Hospital Oakland Research
Institute), and subcloned into pBluescript II SK (-) (Agi-
lent, Santa Clara, CA) between SmaI and HindIII sites.
A PGKneobpA cassette [21] flanked by an frt site on one
end and an frt-loxP sequence on the other was inserted
into the unique EcoRV site in intron 4 in reverse orienta-
tion relative to the orientation of RelA transcription via
blunt-end ligation. Oligonucleotides for creating a DNA
fragment containing a loxP site with an inserted Asp718
site and two AflII ends were synthesized and annealed,
and inserted into a unique AflII site in intron 8. Finally,
MC1tkpA cassette was added into the SalI site of the
multiple cloning site region of the pBluescript for the
enrichment of homologous recombinants via negative
selection [22].
Genetic engineering of mouse embryonic stem (ES) cells
The targeting vector was propagated, purified by cesium
banding, and linearized by NotI. A total of 1 × 107 cells
suspended in DPBS was electroporated with 25 μg DNA
using Gene Pulser (500 μF/230 V, BIO-RAD, Hercules,
CA). The cells were then cultured in 200 μg/ml Geneticin
(G418) and 200 nM 1-(2-deoxy-2-fluoro-1-D-arabino-
furanosyl)-5-iodouracil (FIAU) for 9 days. ES cell colonies
that survived the G418-FIAU drug selection were expan-
ded in three sets of 96-well plates. One set of the cells was
Fig. 3 Confirmation of exon-5-8 removal. The 5′ probe hybridized to XbaI-digested genomic DNA detects 5.6-kb WT bands, 4.2-kb CKO allele
bands, and 7.9-kb KO allele bands. Tail DNA shown in the figure was isolated from pups generated by a female heterozygous for RelACKO allele
and hemizygous for Zp3-cre transgene, and a wild-type C57BL/6J male
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cryopreserved for blastocyst injection; the other two sets
were processed for Southern blot analysis. The 5′ and 3′
flanking probes were hybridized to EcoRV-digested DNA
and Asp718-digested DNA, respectively.
Chimera production and animals
Correctly targeted ES cell clones were injected into
C57BL/6J blastocysts and injected embryos were trans-
ferred to 2.5-day-post-coitum pseudo-pregnant Swiss
Webster female mice. All animal work was approved by
UTMB’s IACUC committee.
Genotyping of the mouse using genomic Southern blot
Mice were genotyped by Southern blot analysis of tail
DNA with 5′-flanking, 3′-flanking, and/or internal probes.
All the probe fragments were generated by PCR, and sub-
cloned into a T-vector. 5′-flanking probe: A 529-bp DNA
was amplified form the BAC DNA with forward primers,
TTGTGGGTAGCTGTGGTCAA, and reverse primer,
CCAGCACTCCAGAAGAAAGG. 3′-flanking probe: A
468-bp DNA was amplified from the BAC DNA with
forward primers, GGGAGAAGTGCAGCCCGGC, and
reverse primer, CCCGGCCTCCCCCTGAGAA. Internal
probe 1: A 561-bp DNA was amplified from the BAC
DNA with forward primers, GATCCAGTGTGTGAAGA
AGC, and reverse primer, GGTTATCAAAAATCGGAT
GT. Internal probe 2: A 209-bp DNA was amplified from
a pool of cDNA originating from mouse embryonic fibro-
blast RNA with forward primers, GATCCAGTGTGTG
AAGAAGC, and reverse primer, GGTTATCAAAAATC
GGATGT. Genomic DNA digested by appropriate res-
triction enzymes was separated on agarose/TAE gels, and
blotted onto Hybond-XL membranes (GE Healthcare,
Waukesha, WI). Blots were hybridized at 65 °C overnight
Fig. 4 Characterization of whole-body RelA-/- and RelACKO/CKO MEF cells. a Mating of a RelA+/- male and female mice produced RelA+/+, RelA+/-
and RelA-/- embryos that were isolated on E12. White arrow indicates the liver, which was observed macroscopically in RelA+/+ and RelA+/-
embryos only, whereas a large hematoma was observed in abdomens of RelA-/- embryos. b Immunohistochemistry for cleaved-caspase 3 and
cleaved-PARP demonstrated paucity of immunostaining in WT embryos for but very robust staining for the enzymes in KO embryos indicative of
massive liver apoptosis. c PCR was performed on DNA isolated from the embryos. Presence of the 7–8 product (425 bp) indicates presence of a
WT allele whereas presence of the 5–8Δ product (335 bp) indicates a RelA mutant allele. d QRT-PCR on RNA isolated from MEF cells provides
evidence that RelA transcripts decreased with decrease in RelA WT allele. e Western blot of proteins extracted from the same MEF cells probed with
anti-RelA Ab (top). β actin staining was used as loading control (bottom). There was no shift in the RelA band suggesting absence of any truncated
form of RelA. These data suggest decrease in the RelA protein with decreasing dose of WT RelA DNA. f RelACKO/CKO MEF cells were transduced with
lentiviral-Cre at multiplicity of infection (MOI) of 1 and 2. Induction of Cre led to a substantial decrease in RelA with increasing MOI
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with radiolabeled and pre-associated probes in 1 M
sodium chloride, 1 % SDS, 10 % dextran sulfate with 100
μg/ml salmon sperm DNA; and washed at 65 °C in 0.2X
SSC, 0.1 % SDS.
Generation of MEF cells and genotyping of the mouse
using PCR
MEF cells were generated as described previously [23].
DNA was isolated from tail biopsies or MEF cells using
phenol:chloroform extraction and ethanol precipitation
followed by PCR. Briefly, tail biopsies or 500K cells were
incubated with 700 μl of digestion buffer (50 mM Tris-
HCl, pH 8; 100 mM EDTA; 100 mM NaCl; 1 % SDS;
350 μg Proteinase K) overnight at 55 °C. Next morning,
700 μl phenol:cholorform (Sigma) was added to each
sample, samples were vortexed and centrifuged at 13,000
RPM for 10 min. Approximately 500 μl of supernatant
was collected and 2× as much ethanol was added to pre-
cipitate the DNA. The mixture was centrifuged, the
supernatant discarded and DNA pellet was re-suspended
in 50 μl of TE buffer. PCR reaction was set up using the
following primers: 5–8Δ F, GCCGGCCAGGCAGCTC
TTAC, and 5–8 Δ R, GGCCAGTCACCATGGCCAGC,
provide a 335 bp product only when RelACKO allele
undergoes recombination and 7–8 F, ACACTGCCGAG
CTCAAGATC, and 7–8 R, AGCTGCATGGAGACTC
GAAC, provide a 425 bp product when WT RelA is
present. Presence of RelACKO alleles was determined by
RelAFlx F, TGCAAACAGACCTCCTTTGTCTTGA,
and RelAFlx R, TCCTGAGACCAGACTCCTCCTCC,
primers which provides a 450 bp product if the CKO
allele is present or 270 bp product for a WT allele. PCR
reaction was denatured at 94 °C for 2 min and subjected
to 35 cycles of 30 s at 94 °C, 30 s at 54 °C, and 60 s
at 72 °C. The PCR products were separated on a 1 %
agarose gel containing ethidium bromide and imaged on a
UV transilliumintor. Col1a2-CreER mice were genotyped
according to instructions by The Jackson Laboratory
(stock no. 016237).
Quantitative RT-PCR (QRT-PCR)
RNA was extracted from MEF cells using Trizol Reagent
(Life Technologies, 15596-026) and was quantified using
NanoDrop 2000 (Thermo Scientific). 1 μg RNA was re-
verse transcribed to cDNA using SuperScript III First-
Strand Synthesis System in a 20 μl reaction according to
the manufacturer’s instruction (Invitrogen, 18080-51).
cDNA was diluted 1:2 and 3 μl of the product was used
in a 30 μl reaction mixture containing 15 μl SybrGreen
mix and 500 nM final concentration of RelA forward,
Fig. 5 Verification of RelA deletion via immunohistochemistry using antibodies targeting RelA N- and C-terminus. RelA+/+ and RelA-/- embryos,
identified by PCR screen, were sectioned and immunostained for RelA with three different antibodies targeting different regions of RelA as
depicted in the diagram. Robust immunostaining of RelA was observed with all three antibodies in the developing liver, brain and vertebrae of
RelA+/+ embryos. In contrast, there was a complete absence of signal in RelA-/- embryos with antibodies targeting the C-terminus and a slight
signal was observed in the liver with antibody targeting the N-terminus, possibly due to antibody cross-reactivity with other RHD containing
proteins. This suggests that the recombined RelA alleles fail to produce RelA protein. N = 3 RelA+/+ and n = 3 Rel-/- embryo tissue sections were
used in each experiment. Representative images from three experiments are shown. All images were captured at 600× magnification. Scale bar
represents 50 microns
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CCGGGATGGCTACTATGAGG, and RelA reverse,
TCTTCACACACTGGATCCCC, primers or 18s rRNA
forward, AGTCCCTGCCCTTTGTACACA, and 18s
rRNA reverse, CGATCCGAGGGCCTCACTA, primers.
The reaction mixtures were aliquoted into a Bio-Rad 96-
well PCR plate and sealed. The plates were denatured at
95 °C for 3 min followed by 40 cycles of 15 s at 95 °C,
60 s at 60 °C and 1 min at 72 °C. PCR products were
subjected to melting curve analysis to ensure that a sin-
gle product was produced. Change in gene expression
was determined using ΔΔCT method. RelA mRNA was
normalized to 18s rRNA.
Immunohistochemistry
Mouse embryos were formalin fixed and paraffin embed-
ded. Tissue sections (6 μm) were deparaffinized and
rehydrated; antigen retrieval was performed with 10 mM
Sodium Citrate, pH6 before blocking with 5 % goat serum
and incubation with anti-RelA C-terminus (Santa Cruz
sc-3702, 1:200, or Abcam ab7970, 1:300), anti-RelA
N-terminus (Santa Cruz sc-109, 1:100), anti-cleaved
capase 3 (Cell Signaling 5A1E, 1:100) or anti-cleaved
PARP antibody (Cell Signaling D64E10, 1:50) overnight at
4 °C. A biotinylated secondary antibody and avidin-biotin
complex (Vector Labs, PK6101) was used to amplify the
signal and DAB substrate (Vector Labs, SK4100) was used
to detect the antigen-antibody complex. Images were
obtained at 600× magnification using a Nikon digital
camera DXM1200F attached to a Nikon Eclipse 80i
microscope.
Semiquantitative Western blot
Whole cell protein lysates were extracted from MEF
cells using RIPA buffer containing protease inhibitor
Fig. 6 Tamoxifen mediated RelA deletion in skin fibroblast in vivo. a To generate fibroblast-specific RelA-/- mice, RelA CKO/CKO mice were
crossed with Col1α2-CreER mice. PCR on DNA from tail biopsies was used to identify the double transgenic. Mice harboring the CKO allele were
identified by the 450 bp product while those containing the WT allele were identified by the 270 bp product. b RelACKO/CKO Cre- and RelA CKO/CKO
Cre + littermates were injected with 1 mg tamoxifen i.p. for 10 days. After 3 weeks, dermal fibroblasts were harvested from both genotypes and
immunostained for RelA after stimulation with vehicle or TNFα (20 ng/ml). Cre + fibroblast had very little cytoplasmic RelA under basal condition and
also displayed less accumulation of RelA in the nucleus after TNFα treatment. White arrows indicate cells that have decreased levels or absence of
nuclear RelA. c QRT-PCR on fibroblasts isolated from Cre + (n = 4) and Cre- (n = 4) mice after tamoxifen treatment suggests significant decrease in RelA
mRNA levels in Cre + fibroblasts. Data are represented as mean +/- SEM, *P < 0.04. d In addition, the same Cre + fibroblasts produce significantly less
RelA protein as determined by Western blot. Data are represented as mean +/- SEM *P < 0.04. A.U is arbitrary units
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cocktail. The resultant protein mixture was fractionated by
10 % SDS-polyacrylamide gel electrophoresis and trans-
ferred to a PVDF membrane. After blocking with 5 % milk
in TBS-tween buffer, the membrane was incubated with
rabbit anti-RelA antibody (Santa Cruz sc-372, 1:1000) and
mouse anti-beta actin (Sigma A5316, 1:10,000) overnight
at 4 °C. Membranes were washed with TBS-tween before
being incubated with IRDye 800-conjugated anti-rabbit
and IRDye 700 conjugated anti-mouse secondary anti-
bodies. RelA and beta-actin bands were detected using
Licor Odyssey infrared scanner. Band densities were
quantified using Image J (NIH) and represented in
arbitrary units.
Tamoxifen mediated genetic recombination and
fibroblast culture
RelACKO/CKO female mice were crossed with Col1α2-
CreER male mice (gift from Dr. Arjun Deb, UNC Chapel
Hill), both on C57Bl/6 background, for three generations
to generate RelACKO/CKO Cre + and RelACKO/CKO Cre- an-
imals. Adult male Cre + and Cre- mice, 3–4 weeks old,
were injected with Tamoxifen (Sigma T5648) 1 mg/day
intraperitoneally for 10 days. Tamoxifen was dissolved in
10 % ethanol and 90 % corn oil for 10 mg/ml working
solution. After another 3 weeks, mice were euthanized
and tissues were harvested for characterization. Skin sam-
ples were incubated with 0.25 % trypsin overnight at 4 °C.
The skin was then minced and digested in 0.14 Wunsch
units/ml Liberase Blendzyme 3 (Roche) containing 1×
antibiotic/antimycotic (Invitrogen) in DMEM/F12 media
for 1–2 h at 37 °C. The skin was further dissociated and
resuspended in DMEM/12 media containing 10 % FBS,
1× antibiotic/antimycotic and nonessential amino acids
(complete media). Cells were centrifuged at 1000×g for 10
mins and the pellet was resuspended in complete media
for culturing. After 3 passages, only surviving cells were
dermal fibroblasts which were characterized via immuno-
fluorescence, QRT-PCR and Western blot.
Statistical analysis
Student’s t-test (2-tail, assuming unequal variance) was
use to analyze difference between two groups. P < 0.05
was considered statistically significant.
Additional file
Additional file 1: Figure S1. Whole cell lysates of A549 cells were
prepared by hypotonic lysis in 50 mM NaCl, 10 mM Tris, pH 7.8, 2 mM
EDTA, 1 % IGEPALCA-630, with protease inhibitor cocktail. Equal volumes
of whole cell lysates were immunoprecipitated overnight with 4 μg of
indicated antibody. Immunoprecipitates were captured on protein A
magnetic beads and washed 4× in PBS. Samples were subjected to
on-bead digestion and assayed for RelA using SID-SRM-MS [24]. Shown is
mean +/- SD of RelA 756 signal relative to internal stable isotope standard
(SIS). Note significant enrichment of RelA signal with each antibody.
(PSD 150 kb)
Abbreviations
CKO: Conditional knock-out; NF-kB: Nuclear factor-kappa b; RHD: Rel
homology domain; TAD: Transcription activation domain
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